Kahira Co. for Pharmaceutical and Chemical Industries was established in 1962 after the integration of three small facilities working in the production of pharmaceutical products (Alpha – Douche – C-pharm) then Beida was joined to this entity later on, they all constituted a concise and limited entity upon that time.

Since 1962, the government decided to expand this entity to be a well-established large scale manufacturing facility and to conclude other production lines for almost all the pharmaceutical dosage forms, to fulfill the extra production demands needed for local market and for most of the Arab countries.

Kahira pharmaceutical company was distinguished as the first one between drug companies in the production of soft gelatin capsules, and the production of Syrups, Lotions, sterile and non-sterile drops, dry powders and granules, ointments and pastes.

The company has a unique sterile dedicated area for the production of cephalosporins that was established by the aid of American expertise and in accordance to the latest international guidelines.

website

www.kahira-pharma.com


Company product catalog

Download

Company product profile

Download

Board Members

Dr/ yaser ahmed  farghly                               Managing Director 

Dr/ Adel taha abd elwahab                               Chairman of the Board

Mrs/ Dina asmail elkialy                                     Executive Member

Mr/ Mohamed abd Moaty metwaly                          Member

Mr/ Salem mohamed salem                                    Member

Audit Committee:

Dr/ Adel taha abd elwahab                                  Chairman

Mrs/ Dina asmail elkialy                                         Member

Mr/ Salem mohamed salem                                      Member

Mr/ Saif Eldeen Abd Elmoaty                                    Member

Mrs/ Hanan  Issa                                                  Member

Company Main Indicators (in thousands of Egyptian Pounds)

Indicator2017-20182018-20192019-2020
Net Operating Revenue9498629629451010431
Interest Expenses000
Net Income45010885170109140
Net Equity373580603664653756
Working Capital238431453935515710
Total Investment844585608934659780
Salaries437174202241192540
Number of workers250524922386